Delivery Order SPE2DB20D2104-SPE2DB24FS45N

Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $12K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $15,940.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2023 and was awarded on November 7, 2023. This is a firm fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,136.08 firm fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The contract has an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $17,584.21 for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 10, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FN74S) valued at $5,539.01 for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract was awarded on March 7, 2022 by the Defense Logistics Agency (DLA), a component of the Department of Defense, with an ultimate completion date of March 8, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $17,677.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. This is a firm fixed-price delivery order contract with a completion date of February 15, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) worth $25,027.02 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The DO is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. The contract has an ultimate completion date of March 1, 2024 and was awarded on February 29, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating full and open...
This federal contract award, valued at $14,876.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, which does not have a set-aside designation, is a Delivery Order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,826.19 for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 9, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order valued at $12,432.70 for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The award has a completion date of February 23, 2024 and uses a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,850.41 firm fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The contract has an ultimate completion date of February 5, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FS45N
    Delivery Order

This federal contract award, valued at $11,746.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s, with a completion date of February 8, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 31, 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. The contract does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 10:18 AM